Analysis of RhoC expression and lymphovascular emboli in inflammatory vs non-inflammatory breast cancers in Egyptian patients.
about
Human cytomegalovirus infection enhances NF-κB/p65 signaling in inflammatory breast cancer patients.Anti-tumor effects of Ganoderma lucidum (reishi) in inflammatory breast cancer in in vivo and in vitro models.Inflammatory breast cancer (IBC): clues for targeted therapiesPatterns of seeking medical care among Egyptian breast cancer patients: relationship to late-stage presentation.Clinical and epidemiologic profile of breast cancer in Tanzania.Survival of inflammatory breast cancer patients compared to non-inflammatory breast cancer patients in EgyptInflammatory breast cancer in north Africa: comparison of clinical and molecular epidemiologic characteristics of patients from Egypt, Tunisia, and MoroccoInflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990-2008.Ganoderma lucidum (Reishi) inhibits cancer cell growth and expression of key molecules in inflammatory breast cancerAssociation of inflammatory and noninflammatory breast cancer with socioeconomic characteristics in the Surveillance, Epidemiology, and End Results database, 2000-2007.Considerations in setting up and conducting epidemiologic studies of cancer in middle- and low-income countries: the experience of a case-control study of inflammatory breast cancer in North Africa in the past 10 years.Molecular and epidemiological characteristics of inflammatory breast cancer in Algerian patients.Assessment of diagnosis of inflammatory breast cancer cases at two cancer centers in Egypt and TunisiaRhoA and RhoC differentially modulate estrogen receptor α recruitment, transcriptional activities, and expression in breast cancer cells (MCF-7).Targeting RhoC by Way of Ribozyme Trangene in Human Breast Cancer Cells and its Impact on Cancer Invasion.
P2860
Q34589568-736AC0D1-CC3C-4E85-818A-24BB6F65D109Q34612111-B51E7307-A936-48C4-BAD8-189F392CD2D9Q34754098-26151A91-F5A7-4D32-81EA-B6314416B603Q34763164-933793F0-8F39-4EDC-9257-0CABD10EEDBAQ34769643-2A2B11FD-EA1E-4D03-AAC6-C673994937C7Q34917731-B3F50C58-FC02-4B37-AEB1-9E0D59976C30Q34918207-B1B52B33-39F6-4E9C-B273-2E168456C143Q34918360-5F7A7AD8-90F7-445A-A78D-E571C3FC1A1BQ35448482-80353D4C-FF09-4CBF-86D2-FDCA08FCA0CFQ35662191-6CAAF1F8-788C-48B0-BFAA-9BB1899FBC68Q36530766-84269C64-374C-4602-8BCB-2022A993A6A6Q36587844-1C66C4B8-129E-49AC-B266-0EE68E6024F4Q36804861-12D411A9-1EC3-4EA2-B3C0-7336C6D118EBQ39085721-9E65EE76-B34E-47C7-8AD2-457E57A413B7Q47102665-BD2750D4-8BC6-429C-B9CB-A01455EB2D3B
P2860
Analysis of RhoC expression and lymphovascular emboli in inflammatory vs non-inflammatory breast cancers in Egyptian patients.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Analysis of RhoC expression an ...... cancers in Egyptian patients.
@ast
Analysis of RhoC expression an ...... cancers in Egyptian patients.
@en
type
label
Analysis of RhoC expression an ...... cancers in Egyptian patients.
@ast
Analysis of RhoC expression an ...... cancers in Egyptian patients.
@en
prefLabel
Analysis of RhoC expression an ...... cancers in Egyptian patients.
@ast
Analysis of RhoC expression an ...... cancers in Egyptian patients.
@en
P2093
P2860
P1433
P1476
Analysis of RhoC expression an ...... cancers in Egyptian patients.
@en
P2093
Ageliki Georgopoulos
Ahmed Hablas
Amr S Soliman
Celina G Kleer
Hoda G Omar
Hussein Khaled
Julie A Douglas
Mousumi Banerjee
Saad Eissa
P2860
P356
10.1016/J.BREAST.2008.11.002
P577
2009-01-20T00:00:00Z